Gene Therapy Targeting Chloride Homeostasis Reverses Cancer-Related Neuropathic Pain
Journal: Journal of Clinical Anesthesia and Management (Vol.1, No. 3)Publication Date: 2016-05-07
Authors : Lingyong Li;
Page : 1-1
Keywords : Gene Therapy; Chloride Homeostasis; Neuropathic Pain;
Abstract
Chronic neuropathic pain is a major, debilitating clinical problem that remains difficult to treat, and over 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation are suffered from neuropathic pain [1]. Because of our limited understanding of the mechanisms underlying neuropathic pain, the existing analgesics for neuropathic pain are not very effective and are associated with various side effects. Gene therapy strategies may target specific chronic pain mechanisms in a tissue-specific manner to be used to correct the abnormal functional proteins, modulate the activity of signal transduction pathways or overproduce various therapeutic secreted proteins.
Other Latest Articles
- The Comparıson of 0.125% Bupıvacaıne+2 mcg/Ml Fentanyl and 0.0625% Bupıvacaıne+2 mcg/Ml Fentanyl in Patıent Controlled Epıdural Analgesıa durıng Labor
- Effects of Cerebral Oxygen Desaturation during One Lung Ventilation on Postoperative Cognitive Function as assessed by Cerebral Oximetry: a Prospective, Observational Study
- A Possible Case of Neurogenic Pulmonary Edema in a Sheep following Intracranial Surgery
- Anticoagulation during Cardiopulmonary bypass in Patients with Heparin-Induced Thrombocytopenia using Heparin and the Platelet Glycoprotein IIb-IIIa Antagonist
- Weak Local Parliament's Role: A Case Study of the West Nusa Tenggara Provincial People's Representative Assembly, 2009-2014
Last modified: 2021-09-11 15:28:00